- Ph.D., Department of Pharmacochemistry, Faculty of Chemistry, Vrije Universiteit, Amsterdam, The Netherlands
- B.S./M.S., Subfaculty of Chemistry, Faculty of Mathematics and Physical Sciences, Vrije Universiteit, Amersterdam, The Netherlands
Department of Pathology and Laboratory Medicine
University of Vermont Cancer Center
Cellular, Molecular, & Biomedical Sciences Program Faculty
Areas of expertise
Research addressing mechanisms by which environmental or endogenous oxidants impact on pulmonary biology and contribute to chronic lung diseases, such as asthma, pulmonary fibrosis and lung cancer.
BIO
Dr. Albert van der Vliet earned his PhD in Pharmacochemistry in 1991 at the Vrije Universiteit in Amsterdam, the Netherlands, and performed postdoctoral training at the University of California at Davis, CA, and at King’s College in London, England. After initial appointments as Assistant and Associate Professor in the Department of Internal Medicine at UC Davis, he relocated to the University of Vermont in 2002, where he is currently a Professor of Pathology and Laboratory Medicine. His research addresses mechanisms by which environmental or endogenous oxidants impact on pulmonary biology and contribute to chronic lung diseases, such as asthma, pulmonary fibrosis and lung cancer. Current research is focused on the role of non-phagocytic NADPH oxidases in lung cell biology and pathology, and their involvement in thiol-based redox signaling and in extracellular matrix remodeling involving heme peroxidases, with the intent of developing novel redox-based diagnostic approaches and targeted therapeutic strategies.
Publications
Bio
Dr. Albert van der Vliet earned his PhD in Pharmacochemistry in 1991 at the Vrije Universiteit in Amsterdam, the Netherlands, and performed postdoctoral training at the University of California at Davis, CA, and at King’s College in London, England. After initial appointments as Assistant and Associate Professor in the Department of Internal Medicine at UC Davis, he relocated to the University of Vermont in 2002, where he is currently a Professor of Pathology and Laboratory Medicine. His research addresses mechanisms by which environmental or endogenous oxidants impact on pulmonary biology and contribute to chronic lung diseases, such as asthma, pulmonary fibrosis and lung cancer. Current research is focused on the role of non-phagocytic NADPH oxidases in lung cell biology and pathology, and their involvement in thiol-based redox signaling and in extracellular matrix remodeling involving heme peroxidases, with the intent of developing novel redox-based diagnostic approaches and targeted therapeutic strategies.